FSMAX
Price
$94.79
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
KMKNX
Price
$85.95
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Ad is loading...

FSMAX vs KMKNX

Header iconFSMAX vs KMKNX Comparison
Open Charts FSMAX vs KMKNXBanner chart's image
Fidelity Extended Market Index
Price$94.79
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
Kinetics Market Opportunities No Load
Price$85.95
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
FSMAX vs KMKNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FSMAX vs. KMKNX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FSMAX is a Buy and KMKNX is a Buy.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. KMKNX (259M). FSMAX pays higher dividends than KMKNX: FSMAX (1.10) vs KMKNX (0.73). FSMAX was incepted earlier than KMKNX: FSMAX (13 years) vs KMKNX (19 years). FSMAX is a more actively managed with annual turnover of: 18.00 vs. KMKNX (5.00). FSMAX has a lower initial minimum investment than KMKNX: FSMAX (0) vs KMKNX (2500). KMKNX annual gain was more profitable for investors over the last year : 107.96 vs. FSMAX (37.46). KMKNX return over 5 years is better than : 245.13 vs. FSMAX (54.93).
FSMAXKMKNXFSMAX / KMKNX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years19 years-
Gain YTD21.432105.37620%
Front LoadN/AN/A-
Min. Initial Investment02500-
Min. Initial Investment IRAN/AN/A-
Net Assets40B259M15,444%
Annual Yield % from dividends1.100.73151%
Returns for 1 year37.46107.9635%
Returns for 3 years2.7394.843%
Returns for 5 years54.93245.1322%
Returns for 10 years86.34408.7121%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRMD0.17N/A
+2.10%
MariMed Inc.
UPMMY26.730.17
+0.64%
UPM-Kymmene Corp.
PUTKY33.600.10
+0.30%
PT United Tractors
SXYAY26.67-0.37
-1.37%
SIKA AG
OTLC0.03N/A
-11.94%
Oncotelic Therapeutics, Inc.